SCHEMBL1102913

SCHEMBL1102913

c1ccc(-c2ccc(-c3cccc(-c4c5ccccc5c(-c5cccc(-c6ccc(-c7ccccc7)cc6)c5)c5ncccc45)c3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 4/20 0.38
MMP2 P08253 1/20 0.37
PIK3CD O00329 1/20 0.37
MAOB P27338 1/20 0.37
NR1H2 P55055 2/20 0.37
NR1H3 Q13133 1/20 0.37
GP6 Q9HCN6 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MKNK1 Q9BUB5 1/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
NPC1 O15118 1/20 0.36
HSP90AA1 P07900 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NISCH Q9Y2I1 1/20 0.36
JAK2 O60674 1/20 0.36
PIK3CA P42336 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
GRIN2D O15399 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1103005 0.98 ESR1 (0.38) TOP1MMP2PIK3CDMAOBNR1H2
SCHEMBL1102851 0.98 TOP1 (0.39) TOP1MMP2PIK3CDMAOBNR1H2
SCHEMBL1102978 0.97 ESR1 (0.39) TOP1MMP2PIK3CDMAOBNR1H2
SCHEMBL1103108 0.93 ESR1 (0.41) TOP1PIK3CDMAOBALDH1A1ESR1
SCHEMBL1103113 0.93 ESR1 (0.41) TOP1PIK3CDMAOBALDH1A1ESR1
SCHEMBL1103138 0.91 CYP11B1 (0.45) TOP1MMP2ALDH1A1ESR1ESR2
SCHEMBL1103134 0.91 CYP11B1 (0.45) TOP1MMP2ALDH1A1ESR1ESR2
SCHEMBL1102945 0.90 CYP11B1 (0.42) TOP1MMP2ALDH1A1ESR1ESR2
SCHEMBL1102864 0.90 TOP1 (0.40) TOP1MMP2PIK3CDMAOBALDH1A1
SCHEMBL1103097 0.90 L3MBTL1 (0.41) TOP1MMP2MAOBALDH1A1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 TOP1 4307/4885MMP2 4794/4885PIK3CD 1649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.